Human Anti centriole and centrosome antibody IgG ELISA kit
E01A0698-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human IgG antibody Laboratories manufactures the invivogen lrl-tl8506 reagents distributed by Genprice. The Invivogen Lrl-Tl8506 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen products are available in stock. Specificity: Invivogen Category: Lrl-Tl8506

True north Cryobox 15mLBlue
Scientific Laboratory Supplies	PK10	EUR 212.4

True north Cryobox 50mLNatural
Scientific Laboratory Supplies	PK10	EUR 210

True north Cryobox 50mLBlue
Scientific Laboratory Supplies	PK10	EUR 210

True north Cryobox1.5/2mLNatural
Scientific Laboratory Supplies	PK10	EUR 162

True north Cryobox1.5/2.0mLGreen
Scientific Laboratory Supplies	PK10	EUR 162

Human true insulin,TI ELISA Kit
SunredBio	96 tests	EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human true insulin,TI ELISA Kit
ChemNorm	96T	EUR 567.6

Chemicals information

TL1A Antibody
3109-002mg	ProSci	0.02 mg	EUR 206.18
Description: TL1A Antibody: Members in the TNF and its receptor superfamilies regulate immune responses and induce apoptosis. DR3 (also termed Wsl-1, Apo-3, TRAMP, and LARD) is preferentially expressed by T lymphocytes and upregulated during T cell activation. The ligand for DR3 was recently identified and designated TL1A. TL1A also binds decoy receptor DcR3/TR6, which is expressed in several lung and colon carcinomas and in some normal tissues. TL1A induces apoptosis and NF-κB activation in DR3 expressing cells, which is antagonized by DcR3. TL1A is upregulated by proinflammatory cytokines TNF and IL-1. TL1A is a longer variant of TL1 (also called VEGI).

TL1A Antibody
3109-01mg	ProSci	0.1 mg	EUR 523.7
Description: TL1A Antibody: Members in the TNF and its receptor superfamilies regulate immune responses and induce apoptosis. DR3 (also termed Wsl-1, Apo-3, TRAMP, and LARD) is preferentially expressed by T lymphocytes and upregulated during T cell activation. The ligand for DR3 was recently identified and designated TL1A. TL1A also binds decoy receptor DcR3/TR6, which is expressed in several lung and colon carcinomas and in some normal tissues. TL1A induces apoptosis and NF-κB activation in DR3 expressing cells, which is antagonized by DcR3. TL1A is upregulated by proinflammatory cytokines TNF and IL-1. TL1A is a longer variant of TL1 (also called VEGI).

TL1A Antibody
3789-002mg	ProSci	0.02 mg	EUR 206.18
Description: TL1A Antibody: Members in the TNF and its receptor superfamilies regulate immune responses and induce apoptosis. DR3 (also termed Wsl-1, Apo-3, TRAMP, and LARD) is preferentially expressed by T lymphocytes and upregulated during T cell activation. The ligand for DR3 was recently identified and designated TL1A. TL1A also binds decoy receptor DcR3/TR6, which is expressed in several lung and colon carcinomas and in some normal tissues. TL1A induces apoptosis and NF-κB activation in DR3 expressing cells, which is antagonized by DcR3. TL1A is upregulated by proinflammatory cytokines TNF and IL-1. TL1A is a longer variant of TL1 (also called VEGI).

TL1A Antibody
3789-01mg	ProSci	0.1 mg	EUR 523.7
Description: TL1A Antibody: Members in the TNF and its receptor superfamilies regulate immune responses and induce apoptosis. DR3 (also termed Wsl-1, Apo-3, TRAMP, and LARD) is preferentially expressed by T lymphocytes and upregulated during T cell activation. The ligand for DR3 was recently identified and designated TL1A. TL1A also binds decoy receptor DcR3/TR6, which is expressed in several lung and colon carcinomas and in some normal tissues. TL1A induces apoptosis and NF-κB activation in DR3 expressing cells, which is antagonized by DcR3. TL1A is upregulated by proinflammatory cytokines TNF and IL-1. TL1A is a longer variant of TL1 (also called VEGI).

Q-Gard TL0 empty pack
QGARDTL00	Scientific Laboratory Supplies	EACH	EUR 130.56

Human TL-1A ELISA Kit
RK00148	Abclonal	96 Tests	EUR 625.2

Human TL1A Antibody
32653-05111	AssayPro	150 ug	EUR 313.2

pcDNA3.1-TLR8 Plasmid
PVTB00528-2c	Lifescience Market	2 ug	EUR 427.2

TL-1A, human recombinant
7219-10	Biovision	each	EUR 248.4

TL-1A, human recombinant
7219-50	Biovision	each	EUR 810

pLKO.1-TLN1 shRNA-1 Plasmid
PVTB00836-3a	Lifescience Market	2 ug	EUR 427.2

pLKO.1-TLR7 shRNA-1 Plasmid
PVTB00092-3a	Lifescience Market	2 ug	EUR 427.2

pLKO.1-TLR7 shRNA-2 Plasmid
PVTB00092-3b	Lifescience Market	2 ug	EUR 427.2

VEGI/TL1 human recombinant
4966-10	Biovision	each	EUR 444

VEGI/TL1 human recombinant
4966-1000	Biovision	each	EUR 9129.6

VEGI/TL1 human recombinant
4966-50	Biovision	each	EUR 1227.6

TNFSF15 Antibody / VEGI / TL1A
RQ4107	NSJ Bioreagents	100 ug	EUR 356.15
Description: Vascular endothelial growth inhibitor (VEGI), also known as TNF-like ligand 1A (TL1A) and TNF superfamily member 15 (TNFSF15), is protein that in humans is encoded by the TNFSF15 gene. The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Two transcript variants encoding different isoforms have been found for this gene.